Milestone Scientific (NYSE:MLSS) Shares Up 7.9% – What’s Next?

Milestone Scientific Inc. (NYSE:MLSS)’s share price was up 7.9% during trading on Friday . The stock traded as high as $0.2948 and last traded at $0.2947. Approximately 343,295 shares traded hands during mid-day trading, a decline of 26% from the average daily volume of 463,582 shares. The stock had previously closed at $0.2730.

Analyst Ratings Changes

Separately, Benchmark reduced their price target on Milestone Scientific from $1.25 to $1.00 and set a “speculative buy” rating for the company in a research note on Thursday, November 20th. One investment analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Milestone Scientific has a consensus rating of “Buy” and a consensus target price of $1.00.

Milestone Scientific Price Performance

The company has a market capitalization of $23.17 million, a price-to-earnings ratio of -4.21 and a beta of 0.94. The business’s 50-day moving average price is $0.34 and its two-hundred day moving average price is $0.50.

Insider Activity

In related news, major shareholder S.R.L. Bp4 sold 100,000 shares of Milestone Scientific stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $0.44, for a total value of $44,000.00. Following the transaction, the insider directly owned 8,896,765 shares of the company’s stock, valued at $3,914,576.60. This trade represents a 1.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Over the last quarter, insiders sold 348,619 shares of company stock worth $159,194. Corporate insiders own 12.51% of the company’s stock.

Institutional Trading of Milestone Scientific

A hedge fund recently bought a new stake in Milestone Scientific stock. Carnegie Investment Counsel acquired a new stake in Milestone Scientific Inc. (NYSE:MLSS) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 164,609 shares of the company’s stock, valued at approximately $105,000. Carnegie Investment Counsel owned about 0.21% of Milestone Scientific at the end of the most recent reporting period. 5.79% of the stock is currently owned by institutional investors.

About Milestone Scientific

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.